Prnews


 Abler Nordic, Livelihoods Funds, Musim Mas, and Temasek Foundation Launch Blended Finance Initiative on Sustainable Oil Palm to Combat Deforestation and Aim to Support at least 400 Smallholders

Abler Nordic, Livelihoods Funds, Musim Mas, and Temasek Foundation L...

March 24, 2025 04:00 AM SAST | By Cision

SINGAPORE, March 24, 2025 /PRNewswire/ -- Impact fund manager Abler Nordic has partnered with Temasek Foundation, a Singapore-based philanthropic...

 GSK's Omjjara (momelotinib) approved in Singapore as the first treatment indicated for myelofibrosis patients with anaemia

GSK's Omjjara (momelotinib) approved in Singapore as the first treat...

March 24, 2025 04:00 AM SAST | By Cision

Approval is for use in myelofibrosis patients with moderate to severe anaemia who are JAK-naive or previously treated with ruxolitinib Nearly...

"Hanwha Life Plants Seeds of AI Innovation in Vietnam"

March 24, 2025 03:30 AM SAST | By Cision

– Fostering AI Talents through Informatics Olympiad Sponsorship 6th Informatics Olympiad concluded with record-breaking participation, sponsored by Ha...

 Chang Gung Memorial Hospital Advances Minimally Invasive Surgery with Robotic Technology

Chang Gung Memorial Hospital Advances Minimally Invasive Surgery wit...

March 24, 2025 03:03 AM SAST | By Cision

Achieves International Recognition with HIMSS Award for Excellence in Smart Healthcare TAOYUAN, March 24, 2025 /PRNewswire/ -- As the demand for surgi...

 HLB Launches the 'Senyum-Senyum Raya' Campaign with a Raya Song by HLB Ambassador, Alif Satar

HLB Launches the 'Senyum-Senyum Raya' Campaign with a Raya Song by H...

March 24, 2025 03:00 AM SAST | By Cision

KUALA LUMPUR, Malaysia, March 24, 2025 /PRNewswire/ -- As the Hari Raya Aidilfitri celebration approaches, Hong Leong Bank and Hong Leong Islamic...

 ArkBio Announces the Completion of Phase III Clinical Study for AK0901 in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in China

ArkBio Announces the Completion of Phase III Clinical Study for AK09...

March 24, 2025 03:00 AM SAST | By Cision

SHANGHAI, March 24, 2025 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced the successful comp...

 ARTERY AT32 MCU Powers Next-Gen Drone Innovation, Advancing Smart Skies and the Low-Altitude Economy

ARTERY AT32 MCU Powers Next-Gen Drone Innovation, Advancing Smart Sk...

March 24, 2025 03:00 AM SAST | By Cision

TAIPEI, March 24, 2025 /PRNewswire/ -- Continuous innovation in drone technology has become a key driving force behind the rapid development of the lo...

 FuSure Reinsurance Secures Long-Term Insurance Authorization and Upgrades to Composite License from Hong Kong Insurance Authority

FuSure Reinsurance Secures Long-Term Insurance Authorization and Upg...

March 24, 2025 03:00 AM SAST | By Cision

HONG KONG, March 24, 2025 /PRNewswire/ -- FuSure Reinsurance ("FuSure") is pleased to announce that, following four years of steady gro...

 Evolve: The Latest GPU Benchmark Suite

Evolve: The Latest GPU Benchmark Suite

March 24, 2025 02:30 AM SAST | By Cision

Revolutionary tool redefines performance evaluation for the graphics industry BREDA, Netherlands, March 24, 2025 /PRNewswire/ -- Traverse Resea...

 CStone Submits Application to the European Medicines Agency for New Indication of Sugemalimab in Stage III Non-Small Cell Lung Cancer

CStone Submits Application to the European Medicines Agency for New...

March 24, 2025 02:15 AM SAST | By Cision

SUZHOU, China, March 24, 2025 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a biopharmaceutical company dedicated to develo...

 Registration is On! 2025 CWIEME Shanghai - Your Gateway to Innovation & Connections

Registration is On! 2025 CWIEME Shanghai - Your Gateway to Innovatio...

March 24, 2025 02:15 AM SAST | By Cision

SHANGHAI, March 24, 2025 /PRNewswire/ -- 2025 CWIEME Shanghai is proud to announce its 10th anniversary that will unfold at the Shanghai World Expo Ex...

 AIM Vaccine's mRNA Shingles Vaccine Approved by the US FDA to Begin Clinical Trials, AI-Enabled mRNA Major Vaccine Product Development Accelerates

AIM Vaccine's mRNA Shingles Vaccine Approved by the US FDA to Begin...

March 24, 2025 02:00 AM SAST | By Cision

HONG KONG, March 24, 2025 /PRNewswire/ -- AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on March 23, 2025...

 Innovent Dosed First Participant in Phase 3 Clinical Study of IBI354 (Novel HER2 ADC) for Platinum-resistant Ovarian Cancer

Innovent Dosed First Participant in Phase 3 Clinical Study of IBI354...

March 24, 2025 02:00 AM SAST | By Cision

SAN FRANCISCO and SUZHOU, China, March 24, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biop...

 Asia's First Single Stock Leveraged & Inverse Products to Debut on HKEX

Asia's First Single Stock Leveraged & Inverse Products to Debut on H...

March 24, 2025 02:00 AM SAST | By Cision

HONG KONG, March 24, 2025 /PRNewswire/ -- CSOP Asset Management Limited (CSOP), the largest Leveraged & Inverse Products (L&I prod...

 Strider Named to Fast Company's 2025 List of Most Innovative Companies

Strider Named to Fast Company's 2025 List of Most Innovative Compani...

March 24, 2025 02:00 AM SAST | By Cision

Strategic intelligence firm ranked in the top ten for most innovative security company TOKYO, March 24, 2025 /PRNewswire/ -- Strider Technologies...

 Clover Announces U.S. IND Clearance and Initiation of Revaccination Clinical Study for RSV Vaccine Candidate SCB-1019

Clover Announces U.S. IND Clearance and Initiation of Revaccination...

March 24, 2025 01:56 AM SAST | By Cision

-- U.S. IND clearance and revaccination trial initiation supports the differentiated global opportunity for Clover's RSV PreF vaccine (SCB-1019)...

 Everest Medicines Announces FDA Clearance of IND Application for Tumor-Associated Antigen Vaccine EVM14

Everest Medicines Announces FDA Clearance of IND Application for Tum...

March 24, 2025 01:30 AM SAST | By Cision

EVM14 received U.S. FDA clearance for its IND application, becoming Everest's first internally discovered program, and the first mRNA therapeutic can...

 CROSSFIRE REBRANDS TO JENSEN HUGHES, EXPANDING ITS FIRE SAFETY AND PERFORMANCE-BASED DESIGN ENGINEERING OFFERINGS

CROSSFIRE REBRANDS TO JENSEN HUGHES, EXPANDING ITS FIRE SAFETY AND P...

March 24, 2025 01:00 AM SAST | By Cision

AUCKLAND, New Zealand, March 24, 2025 /PRNewswire/ -- Jensen Hughes, a global leader in safety, security and risk-based engineering and consult...

 Confidence among small businesses in Singapore rises

Confidence among small businesses in Singapore rises

March 24, 2025 12:00 AM SAST | By Cision

Business sentiment among small businesses in Singapore reached a five-year high in 2024, with a positive outlook expected to continue into 202...

 Volpara Health Announces BOADICEA Integration and Record ECR 2025 Research Presence

Volpara Health Announces BOADICEA Integration and Record ECR 2025 Re...

March 23, 2025 11:00 PM SAST | By Cision

CANBERRA, Australia, March 24, 2025 /PRNewswire/ -- Volpara Health, a global leader in AI-powered breast health solutions and a subsidiary...

Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.

Recent Articles

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.